Clinical Trial Update: Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients [NA]

View source ↗

Summary

This clinical trial update describes a pharmacogenomic study aiming to predict antidepressant responsiveness in patients with depression, sponsored by Samsung M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Samsung Medical Center | Conditions: Depression, Adverse Reaction to Drug | NA | Status: UNKNOWN